Unclaimed Scholar Profile
Are you Vinay Bhomia? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Vinay Bhomia
Technical University of Mombasa•Kenya
Faculty researcher at Technical University of Mombasa (Kenya), specializing in Health & Medical Sciences. [Discipline: Health & Medical Sciences] [Country: Kenya] [Region: East Africa]
#COVID-19 Clinical Research Studies#SARS-CoV-2 and COVID-19 Research#Liver Disease Diagnosis and Treatment#Complementary and Alternative Medicine Studies
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 105 | 50 |
| h-index | 3 | 2 |
| i10-index | 3 | 2 |
Annual Citation Growth
Verified Citations / Year0
20205
2021+40%7
2022+29%9
2023+33%12
2024-8%11
2025-45%6
2026Scholarship Distribution & Proportions7 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (86) • 18% Global Research Impact (19)
7 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (7)
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
Published in International Journal of Infectious Diseases•2021
DOI: 10.1016/j.ijid.2021.03.015 Verified Peer-Reviewed
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study
Published in International Journal of Infectious Diseases•2021
DOI: 10.1016/j.ijid.2021.08.044 Verified Peer-Reviewed
Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study
Published in Human Vaccines & Immunotherapeutics•2021
DOI: 10.1080/21645515.2021.1957413 Verified Peer-Reviewed
Effectiveness and safety of an ayurvedic nutraceutical for improving clinical parameters of liver function in participants with metabolic dysfunction-associated steatotic liver disease: a randomized, placebo-controlled, preliminary phase 2 exploratory clinical trial
Published in Frontiers in Nutrition•2026
DOI: 10.3389/fnut.2026.1761666 Verified Peer-Reviewed
Moellerella wisconsensis ISOLATED FROM STOOL SAMPLE HAVING PROLONGED HISTORY OF DIARRHEA
Published in International Journal of Microbiology Research•2018
DOI: 10.9735/0975-5276.10.2.1009-1010 Verified Peer-Reviewed
0Citations
Showing 1 – 5 of 7 publications
1 / 2